Summary:
Click image to enlarge
The MARITIME-CV and MARITIME-HF studies are looking to see if an investigational medicine can safely:
- Reduce symptoms and the risk of hospitalization and death in people with heart failure.
- Reduce the risk of heart attack, stroke, heart failure, and death in people with heart disease.
Qualified Participants Must:
• Have history of at least one of the following:- Heart attack
- Ischaemic stroke
- Peripheral artery disease (PAD) or Peripheral arterial revascularization/amputation due to the disease
Qualified Participants May Receive:
You will be paid $150.00 per visit to the site. (Up to $3,900 for qualified participants who complete the study)
You may also be reimbursed for reasonable out-of-pocket expenses including travel to take part in the study (Mileage, taxi/Lyft, childcare, etc...)